Steris | STE - Operating Profit



Steris reported $316.5M in Operating Profit for its fiscal quarter ending in June of 2025.


Operating Profit Change Date
3M USD 1.14B 109M Jun/2025
Avanos Medical USD -53660000 63.96M Jun/2025
Baxter International USD 272M 214M Jun/2025
Becton, Dickinson and Co. USD 979M 433M Jun/2025
Boston Scientific USD 942M 21M Jun/2025
CONMED USD 38.16M 22.2M Jun/2025
Cooper Companies USD 175.7M 9.1M Jul/2025
Dexcom USD 212.6M 78.9M Jun/2025
Ecolab USD 737.2M 181.9M Jun/2025
Edwards Lifesciences USD 430.9M 36.1M Jun/2025
Fortive USD 222.2M 11.4M Jun/2025
Getinge SEK 1.08B 900M Dec/2024
Globus Medical USD -125953000 222.96M Jun/2025
Haemonetics USD 70.84M 20.14M Jun/2025
Hologic USD 260.9M 267.9M Jun/2025
Idexx Laboratories USD 373.05M 56.51M Jun/2025
Insulet USD 121.1M 71.8M Jun/2025
Integra LifeSciences USD -1309000 14.65M Jun/2025
Intuitive Surgical USD 746.9M 168.8M Jun/2025
J&J USD 6.94B 6.69B Jun/2025
Masimo USD 64.5M 13.5M Jun/2025
Olympus JPY 16.35B 37.32B Jun/2025
Owens Minor USD 56.75M 56.63M Jun/2025
ResMed USD 455.06M 28.79M Jun/2025
Steris USD 316.5M 105.61M Jun/2025
Stryker USD 1.17B 331M Jun/2025
Tandem Diabetes Care USD -31859000 89.02M Jun/2025
Teleflex USD 177.48M 47.16M Jun/2025
Thermo Fisher Scientific USD 1.92B 200M Jun/2025
Zimmer Biomet Holdings USD 396.4M 57.5M Jun/2025